Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Statistics

Total Valuation

TPEX:6499 has a market cap or net worth of TWD 8.94 billion. The enterprise value is 8.08 billion.

Market Cap	8.94B
Enterprise Value	8.08B

Important Dates

The last earnings date was Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6499 has 96.94 million shares outstanding. The number of shares has increased by 1.40% in one year.

Current Share Class	96.94M
Shares Outstanding	96.94M
Shares Change (YoY)	+1.40%
Shares Change (QoQ)	+4.26%
Owned by Insiders (%)	11.67%
Owned by Institutions (%)	2.41%
Float	55.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.70
PB Ratio	6.35
P/TBV Ratio	7.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.21
EV / Sales	18.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.35

Financial Position

The company has a current ratio of 8.21, with a Debt / Equity ratio of 0.12.

Current Ratio	8.21
Quick Ratio	7.81
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	-0.29
Interest Coverage	-169.42

Financial Efficiency

Return on equity (ROE) is -48.11% and return on invested capital (ROIC) is -26.94%.

Return on Equity (ROE)	-48.11%
Return on Assets (ROA)	-24.90%
Return on Invested Capital (ROIC)	-26.94%
Return on Capital Employed (ROCE)	-43.21%
Weighted Average Cost of Capital (WACC)	7.36%
Revenue Per Employee	11.07M
Profits Per Employee	-15.69M
Employee Count	39
Asset Turnover	0.26
Inventory Turnover	12.21

Taxes

Income Tax	-55,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.67% in the last 52 weeks. The beta is 0.58, so TPEX:6499's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+16.67%
50-Day Moving Average	89.60
200-Day Moving Average	96.74
Relative Strength Index (RSI)	66.26
Average Volume (20 Days)	654,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6499 had revenue of TWD 431.84 million and -611.93 million in losses. Loss per share was -6.55.

Revenue	431.84M
Gross Profit	57.22M
Operating Income	-663.43M
Pretax Income	-663.96M
Net Income	-611.93M
EBITDA	-609.52M
EBIT	-663.43M
Loss Per Share	-6.55

Balance Sheet

The company has 1.07 billion in cash and 162.77 million in debt, with a net cash position of 904.14 million or 9.33 per share.

Cash & Cash Equivalents	1.07B
Total Debt	162.77M
Net Cash	904.14M
Net Cash Per Share	9.33
Equity (Book Value)	1.41B
Book Value Per Share	14.04
Working Capital	1.04B

Cash Flow

In the last 12 months, operating cash flow was -552.40 million and capital expenditures -11.09 million, giving a free cash flow of -563.50 million.

Operating Cash Flow	-552.40M
Capital Expenditures	-11.09M
Depreciation & Amortization	53.91M
Net Borrowing	-49.10M
Free Cash Flow	-563.50M
FCF Per Share	-5.81

Margins

Gross margin is 13.25%, with operating and profit margins of -153.63% and -141.70%.

Gross Margin	13.25%
Operating Margin	-153.63%
Pretax Margin	-153.75%
Profit Margin	-141.70%
EBITDA Margin	-141.15%
EBIT Margin	-153.63%
FCF Margin	n/a

Dividends & Yields

TPEX:6499 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.40%
Shareholder Yield	-1.40%
Earnings Yield	-6.85%
FCF Yield	-6.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 23, 2023. It was a forward split with a ratio of 1.049992864.

Last Split Date	Aug 23, 2023
Split Type	Forward
Split Ratio	1.049992864

Scores

Altman Z-Score	n/a
Piotroski F-Score	3